Brief: Nevro Presents Clinical Data On HFX 10 kHz Therapy
07/06/2022 21:25
June 7 (Reuters) - Nevro Corp NVRO.N :
* CLINICAL DATA PRESENTED AT AMERICAN DIABETES ASSOCIATION
82ND
SCIENTIFIC SESSIONS REINFORCE SIGNIFICANT AND DURABLE BENEFITS
OF NEVRO'S HFX 10 KHZ THERAPY
Source text for Eikon: ID:nPn2vfzNCa
Further company coverage: NVRO.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nevro
See all newsNevro Corp reports results for the quarter ended December 31 - Earnings Summary
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 77 cents a share - Earnings Preview
Nevro Corp expected to post a loss of 78 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Altus Power, Amazon, Nevro